Send feedback

BLM p.Val724Ala

c.2171T>C · rs750687788 · VCV567134

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
AlphaMissense
likely pathogenic
0.8182 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00654%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
2
hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense0.8182likely pathogenic
REVEL0.473indeterminate
SaProtLLR -11.37damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 2.6, phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 46 kb · p 0.035 · regional, not allelic
Overall
CADD27.3PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00654% European (non-Finnish) · 77/1,176,592 alleles
Filtering AF 0.00531% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00491%
Overall 0.0054% 87/1,610,124 alleles · very rare exomes 84/1,457,914 · genomes 3/152,210 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0144% 6,929
European (non-Finnish)grpmax 0.00654% 15,280
Finnishnot grpmax-eligible 0.00156% 63,936

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BLM
Protein
p.Val724Ala
Coding
c.2171T>C
MANE Select
NM_000057
dbSNP
rs750687788
Type
single nucleotide variant
Location
chr15:90765392 (GRCh38)
Gene constraint
LOEUF 0.847 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 61.10 · 16 PDB
Residue 724
the helicase atp-binding domain; an α-helix
Full BLM gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/blm-p-val724ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown